FDA Advisory Committee Votes in Favor of Granting Emergency Use Authorization for the Pfizer-BioNTech COVID-19 Vaccine in Children 5 to <12 Years
Committee reviewed clinical data showing a favorable safety profile and high vaccine efficacy of 90.7%…